Live Cell Imaging Market Size Global Gathering and Future Outlook 2020 to 2027
Live Cell Imaging is a technique to study live cells with
the help of images obtained with imaging systems such as microscopes and high
content screening systems. Over the past few years, the adoption of high
content screening techniques in drug discovery and cell biology has been
continuously rising and so is growing the live cell imaging market.As a result,
live cell imaging is pervasively gaining a considerable prominence, and its
market is garnering colossal accruals. Moreover, the factors such as the increasing
prevalence of chronic diseases and growing government funding in cell-based
research are escalating the market on the global heights.
Acknowledging the exponential accruals, the market is
witnessing currently, Market Research Future (MRFR), in its recently published
study report, asserts that the global live
cell imaging market will register approximately 9 % CAGR between 2018
-2023, garnering impressive growth by 2023.Additional factors driving the
market growth include the various applications of live cell imaging in the
biotech and pharmaceutical industry and the rising prevalence of cancer
worldwide. Furthermore, increasing approvals from regulatory bodies and
spreading awareness foster the market growth.
Key Players:
Some of the fervent players leading the global live cell
imaging market include Leica Microsystems (Germany), Carl Zeiss AG (Germany),
Olympus Corporation (Japan), Nikon Corporation (Japan), Sigma-Aldrich
Corporation (U.S.), Molecular Devices, LCC (U.S.), GE Healthcare (U.K.), PerkinElmer,
Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.),
BioTek Instruments (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6075
Global Live Cell Imaging Market- Competitive Analysis:
The competitive market of live cell imaging appears
fragmented owing to the many large and small players along with the new
entrants churning the competition. Due to the high growth potential and demand
in the market; players also plan to increase production of the products used in
the cell culture.
Global Live Cell Imaging Market- Segments:
MRFR has segmented its analysis into five key dynamics for
enhanced understanding.
·
By Products: Equipment, Consumables, and
Software
·
By Technology: Fluorescence Resonance Energy
Transfer, Fluorescence Recovery After Photobleaching, High-Content Analysis,
Ratiometric Imaging, Fluorescence in Situ Hybridization, Total Internal
Reflection Fluorescence Microscopy, and Multiphoton Excitation Microscopy among
other Technologies.
·
By Application: Cell Biology, Stem Cells, Developmental
Biology, and Drug Discovery among others.
·
By End-user: Pharmaceutical Companies,
Biotechnology Companies, Hospitals, and Diagnostic Laboratories among others.
·
By Regions:
Europe, North America, APAC and Rest-of-the-World.
Global Live Cell Imaging Market- Regional Analysis:
The North American region dominates the global live cell
imaging market with substantial investments made into R&D activities in the
biotech and pharmaceutical sectors.
Furthermore, factors such as the existing well-established healthcare
system, the increasing prevalence of cancer cases, and technological
advancements drive the market growth in the region.
Also, high capitalization in imaging systems as well as
intensive research and development to improve the imaging quality and data
functionality foster the market growth. Strong economic conditions in the
region fuel the market growth, allowing funding required for research and
development. Moreover, the presence of
giant players is impacting the market growth in the region, positively.
The European region heading with the increased focus on
research and development, especially in the biotechnology sector, accounts for
another lucrative market for live cell imaging. Factors such as the government
funding support for R&D expenditure and rising prevalence chronic diseases
are expected to drive the European live cell imaging market. Also, the presence
of some of the notable players such as Leica Microsystems, Carl Zeiss AG, and
GE Healthcare facilitates the market growth in the region.
The Asia Pacific live cell imaging market is rapidly
emerging as a promising market. The
increasing number of research labs define the market landscape in the region.
Also, rapidly improving economic conditions in the region alongside the growing
cancer research activities and developing healthcare technology provide impetus
to market growth in the region.
Japan among other
APAC countries accounts for the largest market for live cell imaging due to the
increase in the prevalence of cancer and demand for live cell imaging
techniques. Whereas, in China, factors
such as rising geriatric population with chronic diseases and the availability
of low-cost diagnostic and treatment options drive the market growth.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/live-cell-imaging-market-6075
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment